1. Home
  2. ABCL vs AMRK Comparison

ABCL vs AMRK Comparison

Compare ABCL & AMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • AMRK
  • Stock Information
  • Founded
  • ABCL 2012
  • AMRK 1965
  • Country
  • ABCL Canada
  • AMRK United States
  • Employees
  • ABCL N/A
  • AMRK N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • AMRK Other Specialty Stores
  • Sector
  • ABCL Health Care
  • AMRK Industrials
  • Exchange
  • ABCL Nasdaq
  • AMRK Nasdaq
  • Market Cap
  • ABCL 719.0M
  • AMRK 725.9M
  • IPO Year
  • ABCL 2020
  • AMRK N/A
  • Fundamental
  • Price
  • ABCL $2.65
  • AMRK $28.66
  • Analyst Decision
  • ABCL Buy
  • AMRK Strong Buy
  • Analyst Count
  • ABCL 3
  • AMRK 3
  • Target Price
  • ABCL $8.50
  • AMRK $46.33
  • AVG Volume (30 Days)
  • ABCL 2.6M
  • AMRK 355.1K
  • Earning Date
  • ABCL 11-04-2024
  • AMRK 11-06-2024
  • Dividend Yield
  • ABCL N/A
  • AMRK 2.77%
  • EPS Growth
  • ABCL N/A
  • AMRK N/A
  • EPS
  • ABCL N/A
  • AMRK 2.44
  • Revenue
  • ABCL $32,962,000.00
  • AMRK $9,929,517,000.00
  • Revenue This Year
  • ABCL N/A
  • AMRK $9.07
  • Revenue Next Year
  • ABCL $38.78
  • AMRK $2.32
  • P/E Ratio
  • ABCL N/A
  • AMRK $11.85
  • Revenue Growth
  • ABCL N/A
  • AMRK 0.59
  • 52 Week Low
  • ABCL $2.34
  • AMRK $24.22
  • 52 Week High
  • ABCL $6.06
  • AMRK $47.39
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 45.91
  • AMRK 16.62
  • Support Level
  • ABCL $2.62
  • AMRK $29.19
  • Resistance Level
  • ABCL $3.18
  • AMRK $31.64
  • Average True Range (ATR)
  • ABCL 0.18
  • AMRK 1.53
  • MACD
  • ABCL -0.01
  • AMRK -0.76
  • Stochastic Oscillator
  • ABCL 22.06
  • AMRK 4.26

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About AMRK A-Mark Precious Metals Inc.

A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.

Share on Social Networks: